Supplementary Note S1: Enrichment of variations and non-synonymous SNPs in different parts of the protein
The set of 673 disease genes that have at least one pathogenic variation and at least one atomic resolution interaction interface was used for calculating the enrichment of inframe and non-synonymous single-nucleotide polymorphisms (SNPs). The ESP SNPs serve as a negative control as most of them are considered to be non-disease related [Consortium, 2010] . The sequences were divided into three regions -'interface' i.e. the atomic-resolution interaction interface, 'interacting domain excluding interface' i.e. all residues in the interacting domains excluding those at the interface and 'non interacting'
i.e. the remainder of the protein which is not interacting.
We calculate odd ratios as described earlier [Wang et al., 2012] . The total sequence length of each region in all proteins divided by the total length of all proteins is the fraction of variations expected by chance (p2). The actual number of variations in each region over all proteins divided by the total number of variations is the fraction of observed variations (p1). Odds ratios are calculated using these expected and observed fractions:
Standard error and Z-scores are calculated using log odds ratios: Here n mut is the number of variations and n res the number of residues.
Supplementary Note S2: Buried surface area calculations
The buried surface area for each co-crystal was calculated using Naccess [Hubbard and Thornton, 1993] . Since multiple co-crystals or several chain pairs within the same crystal structure can represent the same interaction, we define the buried surface area for a particular interaction to be the largest value obtained by Naccess over all structures representing that interaction.
Given the buried surface area for all interactions, we classify them into three categories -low, medium and high. Surface areas below the 40 th percentile are categorized as low, between the 40 th and the 80 th percentile as medium and those above the 80 th percentile as high.
Supplementary Note S3: Biophysical strength of interactions
It has been suggested that the buried surface area of an interacting pair of proteins in a co-crystal structure is proportional to the biophysical strength of the interaction [Jones and Thornton, 1996] . To validate this definition of biophysical strength of interactions, we first calculated co-expression of interacting proteins with low, medium and high buried surface areas respectively (Supplementary Note S2). Expression profiles are obtained from a genome-wide microarray that quantifies transcript levels of human genes at different points in the cell cycle [Whitfield et al., 2002] . To measure co-expression, we calculated the Pearson Correlation Coefficient (PCC) for all pairs of heterodimeric protein-protein interactions. PCC is a metric that quantifies global correlations in expression profiles. We find that interactions with lower buried surface area tend to have significantly weaker global co-expression opposed to interactions with higher buried surface area (P = 0.040 using a two-sided KS test , Fig. 3a) . It is well known that strong stable complexes have higher global co-expression as opposed to weaker or more transient interactions [von Mering et al., 2002; Yu et al., 2008] . Thus, in agreement with previous findings, our results suggest that interactions with higher buried surface area are indeed stronger than ones with lower buried surface area.
To further validate our findings, we calculated the fraction of interactions with different buried surface areas found in stable complexes as reported by two independent publications curated from six major databases [Hu et al., 2009; Kerrien et al., 2012; Keshava Prasad et al., 2009; Licata et al., 2012; Stark et al., 2011; Turner et al., 2010] .
We find that the fraction of interactions in stable complexes is significantly higher for interactions with high buried surface area when compared to those with low buried surface area (P = 0.006 using a cumulative binomial test, Fig. 3b ).
Supplementary Note S4: Accessibility changes in pathogenic variations
Amino acids can be classified as accessible or inaccessible. We quantify this using (ΔG t ) or the free energy of transfer from an organic solvent to water [Janin, 1979] . If (ΔG t ) is negative, then the amino acid is accessible, else it is inaccessible ( Supplementary Fig.   S6 ). We then use these labels to quantify the fraction of accessibility-altering in-frame variations (i.e. accessible to inaccessible or vice versa) in different parts of the protein for surface and buried residues. However, since the propensities for these variations may be inherently different in various parts of the protein, we normalize our calculations by incorporating the distribution of single-nucleotide polymorphisms (SNPs) in our analyses:
Here, En is the enrichment score, F dismut is the fraction of solvent-interaction altering pathogenic variations and F SNP is the fraction of solvent-interacting altering SNPs.
We find that pathogenic variations in both surface and buried residues are significantly more likely (P < 10 -3 using a chi-squared test) to be accessibility-altering than SNPs.
Supplementary Note S5: Polarity changes in pathogenic variations
Amino acids are designated as polar or non-polar based on the nature of their interactions with other charged residues [Lehninger et al., 2008] (Supplementary Fig. S6 ). We then use these labels to quantify the fraction of polarity-altering in-frame variations (i.e. polar to non-polar or vice versa) in different parts of the protein for surface and buried residues.
As described in Supplementary Note S4, we normalize our calculations by incorporating the distribution of single-nucleotide polymorphisms (SNPs) in our analyses. We find that pathogenic variations in both surface and buried residues are significantly more likely (P < 10 -3 using a chi-squared test) to be polarity-altering variations than SNPs.
Supplementary Note S6: Biochemical properties of pathogenic variations and evolutionary changes
To further understand how pathogenic variations differ in their nature from changes occuring during evolution, we calculated the relative propensities of all pairs of aminoacid changes when comparing disease-related in-frame point variations to those that occur during evolution. There are 380 (20x19) possible amino acid pair changes. We obtained the probability of evolutionary changes from a recently updated version of the Dayhoff matrices [Kosiol and Goldman, 2005] and calculated the enrichment of all pairs of amino-acid changes by disease-related in-frame point variations to those that occur during evolution:
Here, En i,j is the enrichment of the of the pathogenic variation from amino acid i to amino acid j in disease as compared to evolution (i, j are indices running from 1 to 20). P (dis) i,j and P (evol) i,j denote the probabilities of observing a pathogenic variation from amino acid i to amino acid j in human disease and evolutionary changes, respectively. N i,j is the number of pathogenic variations from amino acid i to amino acid j.
The values obtained are presented in Supplementary Fig. S7 . Not all 380 pairwise changes are observed as some variations are not observed in disease. To examine whether the fraction of variations that alter structural and biochemical properties are significantly different in disease when compared to evolution, we compared the Δ(ΔG t ) of the amino acid changes with the highest enrichment to the Δ(ΔG t ) of the amino acid changes with the lowest enrichment. We find these two distributions are significantly different (P = 0.010 using a U test; Fig. 4c ), indicating that pathogenic variations are significantly more prone to alter accessibility than evolutionary changes.
Supplementary Note S7: Distribution of disruptive biochemical variations across the protein
We compared the distribution of different pathogenic variations at the interface with other parts of the protein.
Here, En i,j is the enrichment of the pathogenic variation from amino acid i to amino acid j at the interface (i',j are indices running from 1 to 20). P (dis_interface) i,j and P (dis_rest) i,j denote the probabilities of observing a variation from amino acid i to amino acid j at the interface and in the rest of the protein, respectively. These quantities are calculated as described in Supplementary Note S6.
The values obtained are presented in Supplementary Fig. S8 . To examine whether the fraction of variations that alter biochemical properties are significantly at the interface when compared to other parts of the protein, we compared the Δ(ΔG t ) of the amino acid changes with the highest enrichment to the Δ(ΔG t ) of the amino acid changes with no enrichment. We find these two distributions are significantly different (P = 0.034 using a U test; Fig. 4d ), indicating that pathogenic variations at the interface are most prone to altering accessibility.
Supplementary Table S1
Buried surface areas of interactions calculated using Naccess.
Columns 1 and 2 contain the Entrez gene ids of the interacting proteins and column 3 contains the buried surface area in Å 2 .
